Why Is Robinhood Defending Its AMC Stock Token?
Robinhood CEO Vlad Tenev has rejected AMC Entertainment’s argument that companies should have the power to stop third parties from issuing tokenized products linked to their publicly traded shares, escalating a dispute over who controls the emerging market for synthetic equity exposure.
AMC CEO Adam Aron last week accused Robinhood of creating what he described as a “fake market” for AMC shares and threatened to involve the U.S. Securities and Exchange Commission. AMC has said it has no connection to Robinhood’s AMC-linked token and does not approve of the product.
Tenev responded publicly on Wednesday, arguing that an issuer controls the rights and obligations attached to the shares it issues but does not control every financial instrument another company may create using those shares as a reference asset.
“Issuers should have control and do have control over the rights and obligations of the stock that they issue, but that doesn’t mean they control everything about it,” Tenev said. “In particular, they don’t control other companies issuing their own securities that reference those shares.”
He added that Robinhood’s stock tokens “should not automatically require issuer consent.”
What Do Robinhood Stock Token Holders Actually Own?
The dispute is partly about terminology. Robinhood’s products provide economic exposure to publicly traded companies, but token holders do not directly own the underlying shares.
Tenev said each stock token is backed 1:1 by an underlying share held as collateral. The token itself is structured as a debt security rather than equity in the referenced company. Holders receive the economic benefit of dividends but do not receive the voting rights attached to the shares backing the tokens.
That distinction is central to AMC’s objection. The token can trade using AMC as its reference asset without giving its holder the legal rights of an AMC shareholder or requiring AMC to participate in the issuance.
Tenev was also asked whether Robinhood intends to exercise voting rights attached to shares it holds as collateral for the tokens. He said the company has not yet announced how those shares will be voted.
Investor Takeaway
The AMC dispute exposes a basic fault line in stock tokenization: investors can receive price exposure to a company without owning its shares, while the company itself may have little control over creation of the product. That distinction could become increasingly important as tokenized equity markets expand.
Why Does Issuer Consent Matter?
Aron has demanded that Robinhood cease trading tokens tied to AMC and has questioned whether third parties should be able to build parallel instruments around a company’s stock without its approval.
Robinhood takes the opposite view. Its argument effectively treats stock tokens as separate financial securities whose reference to another company’s shares does not give that company an automatic veto over issuance.
The disagreement could have implications well beyond AMC. If issuer consent is unnecessary, tokenization platforms could potentially create large catalogs of equity-linked instruments without negotiating individually with each public company. Requiring consent would give issuers much greater control but could slow expansion of tokenized stock markets.
The structure also differs from placing an actual company share directly on a blockchain. Graham Rodford, CEO of U.K.-regulated digital asset exchange Archax, has argued that there is an important difference between tokenizing the share itself and issuing another instrument that merely tracks it.
Can Token Prices Break Away From the Underlying Shares?
Another concern is whether thin onchain markets can maintain reliable links to the prices of their reference stocks.
Securitize CEO Carlos Domingo pointed to an AMC-linked token trading pair that changed hands at roughly 60 times AMC’s reference share price. The episode illustrated how prices displayed in individual token liquidity pools can diverge sharply from the underlying equity when trading conditions are thin or the pair has unusual market mechanics.
That does not necessarily mean the collateral backing Robinhood’s tokens has disappeared or that AMC’s exchange-listed share price has changed. It does show why the mechanics of the token, the liquidity venue and the underlying collateral matter when assessing products marketed as stock exposure.
The AMC-Robinhood fight therefore extends beyond one company’s objection to its name appearing in a token market. The larger question is whether tokenized equity exposure should be treated primarily as an extension of existing securities markets or as a separate class of financial instruments that can reference public companies without their involvement.
